HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care

Simple item page
dc.contributor.authorCommittee on HIV Screening , and Access to Care
dc.contributor.authorInstitute , of Medicine
dc.date.accessioned2019-08-14T15:04:04Z
dc.date.available2019-08-14T15:04:04Z
dc.date.issued2011
dc.description.abstractWith the widespread use of highly active anti-retroviral treatment (HAART), HIV has become a chronic, rather than a fatal, disease. But for their treatment to succeed, patients require uninterrupted care from a health care provider and uninterrupted access to anti-HIV medications. The IOM identifies federal, state, and private health insurance policies that inhibit HIV-positive individuals from initiating or continuing their care.
dc.description.urihttp://www.nap.edu/catalog.php?record_id=13057
dc.identifierhttps://doi.org/10.13016/ymue-avve
dc.identifier.citationCommittee on HIV Screening , and Access to Care and Institute , of Medicine (2011) HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care. National Academies Press, Washington, D.C..
dc.identifier.isbn0-309-16419-2
dc.identifier.otherEprint ID 2987
dc.identifier.urihttp://hdl.handle.net/1903/23614
dc.publisherNational Academies Press
dc.subjectAccess To Healthcare
dc.subjectPolicy
dc.subjectHIV/Aids
dc.subjectHIV
dc.subjectchronic disease
dc.subjectaccess
dc.subjecthealth insurance
dc.titleHIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care
dc.typeBook

Files

Collections

Minority Health and Health Equity Archive